{ event: "article_read", name: `Discover the science behind Tolebrutinib: a BTK inhibitor designed to slow MS disability progression by modulating adaptive and innate immunity`, author: ``, tags: `Multiple Sclerosis`, publication_date: ``, interaction_type: "content" } 
Discover the science behind Tolebrutinib: a BTK inhibitor designed to slow MS disability progression by modulating adaptive and innate immunity
Related articles
MAT-BH-2500365-V1-June 2025